Bizalimogene ralaplasmid

DB16113Investigational

Bizalimogene ralaplasmid is under investigation in clinical trial NCT03499795 (VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 And/or HPV-18 Related Anal or Anal/peri-anal, High Grade...

Mechanism: Pharmacologically active on Protein E6 and Protein E7
Curator reviewed
Code names: pGX-3002 · VGX-3100

Resolves to

Compound

UNIID8W2DVO5ZJCAS1977488-08-6

Targets

P03126E6 P03129E7 P06463E6

What you can answer from here — as of July 08, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with Bizalimogene ralaplasmid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account